Cargando…
Global expression of AMACR transcripts predicts risk for prostate cancer – a systematic comparison of AMACR protein and mRNA expression in cancerous and noncancerous prostate
BACKGROUND: The high false negative rates for initial prostate biopsies refer a large number of the men for repeat biopsies each year. Therefore, biomarkers associated with high risk of the presence of malignancy in histologically benign biopsies could provide a tool to discriminate the patients who...
Autores principales: | Alinezhad, Saeid, Väänänen, Riina-Minna, Ochoa, Natalia Tong, Vertosick, Emily A., Bjartell, Anders, Boström, Peter J, Taimen, Pekka, Pettersson, Kim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4772680/ https://www.ncbi.nlm.nih.gov/pubmed/26928323 http://dx.doi.org/10.1186/s12894-016-0128-8 |
Ejemplares similares
-
The expressions of AMACR and iNOS in prostate adenocarcinomas
por: Ozgur, Tumay, et al.
Publicado: (2013) -
Altered PCA3 and TMPRSS2-ERG expression in histologically benign regions of cancerous prostates: a systematic, quantitative mRNA analysis in five prostates
por: Väänänen, Riina-Minna, et al.
Publicado: (2015) -
Validation of Novel Biomarkers for Prostate Cancer Progression by the Combination of Bioinformatics, Clinical and Functional Studies
por: Alinezhad, Saeid, et al.
Publicado: (2016) -
Correction: Validation of Novel Biomarkers for Prostate Cancer Progression by the Combination of Bioinformatics, Clinical and Functional Studies
por: Alinezhad, Saeid, et al.
Publicado: (2016) -
Urine Exosomal AMACR Is a Novel Biomarker for Prostate Cancer Detection at Initial Biopsy
por: Jin, Xin, et al.
Publicado: (2022)